SCHEDULE OF DERIVATIVE LIABILITIES (Details) - USD ($)	9 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Balance beginning of period – March 31	$ 1,435,668	$ 759,065
New Issuance	649,533	642,417
Change in fair value of derivative liabilities	487,272	(142,830)
Reduction due to preferred shares converted [Note 9]	(1,065,202)	(119,359)
Balance end of period – December 31	1,507,271	1,139,293
Convertible Debt [Member]
Debt Instrument [Line Items]
Balance beginning of period – March 31	991,866	1,008,216
New Issuance		1,224,933
Change in fair value of derivative liabilities	(32,525)	386,845
Conversion to common shares	(490,972)	(39,089)
End of derivative treatment		(1,652,572)
Convertible note redemption	(8,320)
Balance end of period – December 31	$ 460,059	$ 928,333